- Record: found
- Abstract: found
- Article: not found
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Ken Ohara
1 ,
Takahiro Masuda
1 ,
Takuya Murakami
1 ,
Toshimi Imai
1 ,
Hiromichi Yoshizawa
1 ,
Saki Nakagawa
1 ,
Mari Okada
1 ,
Atsushi Miki
1 ,
Akihiro Myoga
1 ,
Taro Sugase
1 ,
Chuji Sekiguchi
2 ,
Yasuharu Miyazawa
3 ,
Akito Maeshima
1 ,
Tetsu Akimoto
1 ,
Osamu Saito
1 ,
Shigeaki Muto
1 ,
Daisuke Nagata
1
Dec 22 2018
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are an antihyperglycemic drug with diuretic properties. We recently reported that an SGLT2 inhibitor ameliorated extracellular fluid expansion with a transient increase in urinary Na+ excretion. However, the effects of SGLT2 inhibitors on fluid distribution in comparison to conventional diuretics remain unclear.